U.S. Diagnostic reports profitable year

Article

Imaging services provider U.S. Diagnostic reported a return to profitability in 1998, a sign that the company's ongoing recovery effort is proving successful. For the year (end-December), USDL of West Palm Beach, FL, reported net income of $4.8 million,

Imaging services provider U.S. Diagnostic reported a return to profitability in 1998, a sign that the company's ongoing recovery effort is proving successful. For the year (end-December), USDL of West Palm Beach, FL, reported net income of $4.8 million, compared with a net loss of $116.7 million in 1997. USDL had revenues for the year of $195.7 million, compared with $216.2 million the year before.

USDL was able to turn a profit on lower revenues by selling off many underperforming imaging centers, according to Joseph Paul, president and CEO. The company also reduced its debt through restructuring in late 1998 and early 1999. USDL's lower debt load and an expected 5% to 7% growth in procedure volume at its centers should help the company improve its performance this year, Paul said.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.